Tempus AI TEM
US equityMarket cap rank #1424Health Information ServicesAI application softwareAI medical concept stocks
$54.04 −$5.57 (-9.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $54.93 +1.65%
Open$57.78
Prev close$59.61
Day range$53.26 – $58.35
Volume7.44M
Market cap$9.86B
P/E (TTM)–
Dividend yield–
TEM Stock News
Headlines matching Tempus AI or the TEM ticker, most recent first.
- Rothschild & Co Redburn Initiates Tempus AI(TEM.US) With Hold Rating, Announces Target Price $67
- Tempus AI(TEM.US) 10% Shareholder Sells US$19.37 Million in Common Stock
- Form 144 | Tempus AI(TEM.US) Officer Proposes to Sell 19.51 Million in Common Stocks
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Avantor (AVTR)
- Cantor Fitzgerald Initiates Tempus AI(TEM.US) With Buy Rating, Announces Target Price $80
- Tempus AI(TEM.US) 10% Shareholder Sells US$16.11 Million in Common Stock
- Form 144 | Tempus AI(TEM.US) Officer Proposes to Sell 13.99 Million in Common Stocks
- H.C. Wainwright Maintains Tempus AI(TEM.US) With Buy Rating, Raises Target Price to $66 Positive
- CCORF Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $80
- Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB)
- Piper Sandler Upgrades Tempus AI(TEM.US) to Buy Rating, Raises Target Price to $76 Positive
- Piper Sandler Maintains Tempus AI(TEM.US) With Hold Rating, Cuts Target Price to $56 Negative
- A Quick Look at Today's Ratings for Tempus AI(TEM.US), With a Forecast Between $50 to $70
- H.C. Wainwright Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $56
- BTIG Maintains Tempus AI(TEM.US) With Buy Rating, Raises Target Price to $80 Positive
No comments yet — be the first to weigh in on TEM.
Sign in to join the discussion.